SCHEMBL6810470

SCHEMBL6810470

C1=C(c2ccccn2)CCC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.50
CYP1A2 P05177 3/20 0.50
LMNA P02545 3/20 0.50
CCR1 P32246 2/20 0.50
CCR5 P51681 2/20 0.50
CCR8 P51685 2/20 0.50
POLB P06746 1/20 0.50
METAP1 P53582 1/20 0.50
BLM P54132 1/20 0.50
HIF1A Q16665 1/20 0.50
DOHH Q9BU89 1/20 0.50
P4HTM Q9NXG6 1/20 0.50
TDP1 Q9NUW8 3/20 0.49
GRM5 P41594 2/20 0.46
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
TP53 P04637 3/20 0.43
ALOX15 P16050 2/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7071127 0.94 TDP1 (0.56) KDM4ECYP1A2LMNACCR1CCR5
SCHEMBL30374920 0.94 TDP1 (0.56) KDM4ECYP1A2LMNACCR1CCR5
SCHEMBL29742341 0.92 TDP1 (0.54) KDM4ECYP1A2LMNACCR1CCR5
SCHEMBL9039356 0.92 TDP1 (0.54) KDM4ECYP1A2LMNACCR1CCR5
SCHEMBL29742339 0.92 TDP1 (0.54) KDM4ECYP1A2LMNACCR1CCR5
SCHEMBL245713 0.92 TDP1 (0.54) KDM4ECYP1A2LMNACCR1CCR5
SCHEMBL8902116 0.85 KDM4E (0.56) KDM4ECYP1A2LMNACCR1CCR5
SCHEMBL17721314 0.78 KDM4E (0.43) KDM4ECYP1A2LMNACCR1CCR5
SCHEMBL10382864 0.74 PPARA (0.39) CYP1A2TDP1GRM5F2RL1
SCHEMBL2174836 0.73 KDM4E (0.46) KDM4ECYP1A2LMNACCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731207-A2 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS Merck Sharp & Dohme LLC (US) 2026-04-29 EP disclosed
WO-2025006293-A2 INHIBITORS OF HUMAN RESPIRATORY SYNCYTIAL VIRUS AND METAPNEUMOVIRUS MERCK SHARP & DOHME LLC (US) 2025-01-02 WO disclosed
US-6733905-B2 SUCH AS BIS(1-(2-PYRIDYL)CYCLOPENTENE-N,C2)(ACETYLACETNONATO) IRIDIDIUM(III); ELECTROLUMINESCENCE/PHOSPHORESCENCE; EFFICIENCY; LOW EXCITATION STATE CANON KABUSHIKI KAISHA (JP) 2004-05-11 US disclosed
US-20020094453-A1 Metal coordination compound, luminescence device and display apparatus CANON KABUSHIKI KAISHA (JP) 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094453-A1 Metal coordination compound, luminescence device and display apparatus ICOSLG, CCRL2, ZC3HAV1L KDM4E 3942/4885CYP1A2 2361/4885LMNA 4804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.